Warning Labels on Drugs
The New York Times
By Peter J. Pitts
June 10, 2011
To the Editor:
“Side Effects? These Drugs Have a Few” (Week in Review, June 5) rightly ridiculed the growing number of warning labels on prescription drugs. But it’s the Food and Drug Administration’s job to promote the safe and effective use of medications and medical technology.
Unfortunately, the current liability system encourages well-financed tort lawyers to view new product warnings or withdrawal decisions as signals to file lawsuits in hopes of securing a quick payday. Such irresponsible litigation doesn’t make America’s health care system safer — it just helps a small number of lawyers get rich.
PETER PITTS
New York, June 6, 2011
The writer is president of the Center for Medicine in the Public Interest and a former F.D.A. associate commissioner.
Featured
Animal health and human health are inextricably linked
May 15, 2012
Drug Shortages and the Role of the Middle Man
April 13, 2012
Obamacare's Medical Mercenaries
April 13, 2012
Social Networks
Receive latest news & event updates
Provide email below:
Like CMPI on Facebook
Follow CMPI on Twitter
Connect with CMPI on LinkedIn
Watch our Videos on CMPI YouTube Channel
Subscribe to Receive CMPI RSS Feeds
Donate
Please consider a tax-deductible contribution to CMPI. Your support is appreciated.